Skip to Content
Home eXciteOSA®
eXciteOSA product

eXciteOSA® – A Daytime Therapy for Mild Obstructive Sleep Apnea and Snoring

eXciteOSA® therapy is the only FDA-authorized, clinically proven daytime therapy for mild obstructive sleep apnea (OSA) and snoring. eXciteOSA® targets the root cause of mild OSA and snoring rather than relieving the symptoms. Click the button below to learn more about the product in the brochure or contact eXciteOSA at:

Shop Now!

Product Brochure

About the OSA Therapy

Oftentimes, OSA is caused by collapsed tissue in the airway. eXciteOSA® prevents the airway from collapsing by improving the muscle function of the tongue through stimulation therapy. Improvement of muscle function not only prevents the upper airway tissue from collapsing but ensures that the upper airway remains open during sleep, thereby improving sleep quality. Click the button below to view the therapy level guide.

Therapy Level Guide

How eXciteOSA® Works

eXciteOSA® is clinically proven to significantly reduce mild obstructive sleep apnea and snoring.1,2,3

Here’s the timeline for treatment:

  • First six weeks: 20-minute sessions once per day
  • After six weeks: 20-minute sessions twice per week

The eXciteOSA® device is convenient and simple to use:

  1. The mouthpiece gets positioned onto your tongue.
  2. The app activates and customizes each therapy session, making this experience unique to you.
  3. The app tracks your progress and keeps you focused on therapy goals.

View or download the Quick Start Guide by clicking the button below.

Quick Start Guide

Key Clinical Results

eXciteOSA® offers a convenient daytime therapy for noticeable night-time results:

  • 90% of patients reported a reduction in snoring time3
  • 89% of bed partners reported a reduction of their partners snoring3
  • 79% of sleep apnea patients achieved a reduction in sleep apnea measures3

View the product and technical specifications below.

Product Specs How Much Does eXciteOSA Cost?

Learn More and Contact Us

This item was just approved by the FDA. If you are interested in this product or would like more information, contact us at:

Shop Now! 


1 E.Wessoleck et al. Intraoral electrical muscle stimulation in the treatment of snoring. Somnologie (Berl). 2018; 22(Suppl 2): 47–52.
2 A.Sama et al. Daytime Intraoral Neurostimulation with Snoozeal® for treatment of Snoring and Mild Sleep Apnea. CHEST Annual Meeting Notes, 2018.
 eXciteOSA® White Paper (2020). Clinical study of 115 patients with snoring or mild OSA (Apnea-Hypopnea Index (AHI) <15 n=65) completed the trial. Objective snoring and respiratory parameters were recorded with 2 consecutive WatchPAT® night sleep studies before and after the use of the device. An intra-oral tongue stimulator device was used for 20 mins, once a day for 6-week period. (Internal publication by SMT for educational purposes and submission.)